City

Memphis (1)

Philadelphia (1)

Saint Louis (1)

San Diego (1)

San Francisco (1)

Overall Status

Active, not recruiting (1)

Recruiting (1)

Phase

n/a (1)

phase 1 (1)

Sponsor

St. Jude Children's Research Hospital (1)

University of California, San Francisco (1)

Collaborator

Ashion Analytics (1)

Eli Lilly and Company (1)

Pacific Pediatric Neuro-Oncology Consortium (1)

St. Baldrick's Foundation (1)

University of Washington (1)

Washington University School of Medicine (1)

Intervention

cyclophosphamide (1)

filgrastim (1)

gemcitabine (1)

peg-filgrastim (1)

prexasertib (1)

specialized tumor board treatment plan (1)

Study Documents

Intervention Type

biological (1)

drug (1)

other (1)

Funder Type

Other (2)

Study Type

Interventional (2)

medulloblastoma recurrent

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Medulloblastoma, Medulloblastoma, Childhood, Medulloblastoma Recurrent Trial in United States (Specialized Tumor Board Treatment

Recruiting

Medulloblastoma
+2 more

Specialized Tumor Board Treatment Plan

San Diego, California
+3 more

Dec 28, 2022

Brain Tumor, Brain Tumor, Recurrent, Brain Tumor, Refractory Trial in Memphis (Prexasertib, Cyclophosphamide, Gemcitabine)

Active, not recruiting

Brain Tumor
+12 more

Prexasertib
+4 more

Memphis, Tennessee

St. Jude Children's Research Hospital

Oct 20, 2022